Alfred Zippelius

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 32

Top Topics

Systematic Review

Patients With Inflammatory Bowel Disease

Top Venues

Journal for immunotherapy of cancer

Nature communications

Science advances

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Eveline Daetwyler, Till Wallrabenstein, David König, Laura C Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Laubli
Corticosteroid-resistant immune-related adverse events: a systematic review. Journal for immunotherapy of cancer 12 (1) (2024)
Eveline Daetwyler, Till Wallrabenstein, David König, Laura C Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Laubli
Corticosteroid-resistant immune-related adverse events: a systematic review. Journal for immunotherapy of cancer 12 (1) (2024)
Eveline Daetwyler, Till Wallrabenstein, David König, Laura C Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Laubli
Corticosteroid-resistant immune-related adverse events: a systematic review. Journal for immunotherapy of cancer 12 (1) (2024)
David König, Michael T Sandholzer, Sarp Uzun, Andreas Zingg, Reto Ritschard, Helen Thut, Katharina Glatz, Elisabeth Artemis Kappos, Dirk J Schaefer, Christoph Kettelhack, Jakob R Passweg, Andreas Holbro, Katharina Baur, Michael Medinger, Andreas S Buser, Didier Lardinois, Lukas T Jeker, Nina Khanna, Frank Stenner, Benjamin Kasenda, Krisztian Homicsko, Matthias S Matter, Natalia Rodrigues Mantuano, Alfred Zippelius, Heinz Laubli
Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes. Cancer immunology research 12 (7) (2024)
Eveline Daetwyler, Till Wallrabenstein, David König, Laura C Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Laubli
Corticosteroid-resistant immune-related adverse events: a systematic review. Journal for immunotherapy of cancer 12 (1) (2024)
Alessandro Vacchini, Andrew Chancellor, Qinmei Yang, Rodrigo Colombo, Julian Spagnuolo, Giuliano Berloffa, Daniel Joss, Ove Øyås, Chiara Lecchi, Giulia De Simone, Aisha Beshirova, Vladimir Nosi, José Pedro Loureiro, Aurelia Morabito, Corinne De Gregorio, Michael Pfeffer, Verena Schaefer, Gennaro Prota, Alfred Zippelius, Joerg Stelling, Daniel Häussinger, Laura Brunelli, Peter W Villalta, Marco Lepore, Enrico Davoli, Silvia Balbo, Lucia Mori, Gennaro De Libero
Nucleobase adducts bind MR1 and stimulate MR1-restricted T cells. Science immunology 9 (95) (2024)
David König, Michael T Sandholzer, Sarp Uzun, Andreas Zingg, Reto Ritschard, Helen Thut, Katharina Glatz, Elisabeth Artemis Kappos, Dirk J Schaefer, Christoph Kettelhack, Jakob R Passweg, Andreas Holbro, Katharina Baur, Michael Medinger, Andreas S Buser, Didier Lardinois, Lukas T Jeker, Nina Khanna, Frank Stenner, Benjamin Kasenda, Krisztian Homicsko, Matthias S Matter, Natalia Rodrigues Mantuano, Alfred Zippelius, Heinz Laubli
Melanoma clonal heterogeneity leads to secondary resistance after adoptive cell therapy with tumor-infiltrating lymphocytes. Cancer immunology research (2024)
Eveline Daetwyler, Till Wallrabenstein, David König, Laura C Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Laubli
Corticosteroid-resistant immune-related adverse events: a systematic review. Journal for immunotherapy of cancer 12 (1) (2024)
Eveline Daetwyler, Till Wallrabenstein, David König, Laura C Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Laubli
Corticosteroid-resistant immune-related adverse events: a systematic review. Journal for immunotherapy of cancer 12 (1) (2024)
Alessandro Vacchini, Andrew Chancellor, Qinmei Yang, Rodrigo Colombo, Julian Spagnuolo, Giuliano Berloffa, Daniel Joss, Ove Øyås, Chiara Lecchi, Giulia De Simone, Aisha Beshirova, Vladimir Nosi, José Pedro Loureiro, Aurelia Morabito, Corinne De Gregorio, Michael Pfeffer, Verena Schaefer, Gennaro Prota, Alfred Zippelius, Joerg Stelling, Daniel Häussinger, Laura Brunelli, Peter W Villalta, Marco Lepore, Enrico Davoli, Silvia Balbo, Lucia Mori, Gennaro De Libero
Nucleobase adducts bind MR1 and stimulate MR1-restricted T cells. Science immunology 9 (95) (2024)
Marcel Philipp Trefny, Nicole Kirchhammer, Priska Auf der Maur, Marina Natoli, Dominic Schmid, Markus Germann, Laura Fernandez Rodriguez, Petra Herzig, Jonas Lötscher, Maryam Akrami, Jane C Stinchcombe, Michal A Stanczak, Andreas Zingg, Melanie Buchi, Julien Roux, Romina Marone, Leyla Don, Didier Lardinois, Mark Wiese, Lukas T Jeker, Mohamed Bentires-Alj, Jérémie Rossy, Daniela S Thommen, Gillian M Griffiths, Heinz Läubli, Christoph Hess, Alfred Zippelius
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy. Nature communications 14 (1) (2023)
Omar S Sarkar, Howard Donninger, Numan Al Rayyan, Lewis C Chew, Bryce Stamp, Xiang Zhang, Aaron Whitt, Chi Li, Melissa Barousse Hall, Robert A Mitchell, Alfred Zippelius, John Eaton, Jason A Chesney, Kavitha Yaddanapudi
Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy. Science advances 9 (26) (2023)
Dominic Schmid, Priska Auf der Maur, Marcel Philipp Trefny, Alfred Zippelius
Unraveling T cell exhaustion: genetic screening meets in vitro modeling. Cancer research (2023)
Marcel Philipp Trefny, Nicole Kirchhammer, Priska Auf der Maur, Marina Natoli, Dominic Schmid, Markus Germann, Laura Fernandez Rodriguez, Petra Herzig, Jonas Lötscher, Maryam Akrami, Jane C Stinchcombe, Michal A Stanczak, Andreas Zingg, Melanie Buchi, Julien Roux, Romina Marone, Leyla Don, Didier Lardinois, Mark Wiese, Lukas T Jeker, Mohamed Bentires-Alj, Jérémie Rossy, Daniela S Thommen, Gillian M Griffiths, Heinz Läubli, Christoph Hess, Alfred Zippelius
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy. Nature communications 14 (1) (2023)
Marcel Philipp Trefny, Nicole Kirchhammer, Priska Auf der Maur, Marina Natoli, Dominic Schmid, Markus Germann, Laura Fernandez Rodriguez, Petra Herzig, Jonas Lötscher, Maryam Akrami, Jane C Stinchcombe, Michal A Stanczak, Andreas Zingg, Melanie Buchi, Julien Roux, Romina Marone, Leyla Don, Didier Lardinois, Mark Wiese, Lukas T Jeker, Mohamed Bentires-Alj, Jérémie Rossy, Daniela S Thommen, Gillian M Griffiths, Heinz Läubli, Christoph Hess, Alfred Zippelius
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy. Nature communications 14 (1) (2023)
Omar S Sarkar, Howard Donninger, Numan Al Rayyan, Lewis C Chew, Bryce Stamp, Xiang Zhang, Aaron Whitt, Chi Li, Melissa Barousse Hall, Robert A Mitchell, Alfred Zippelius, John Eaton, Jason A Chesney, Kavitha Yaddanapudi
Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy. Science advances 9 (26) (2023)
Laura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, Marcel Philipp Trefny, Richard Klar, Nicole Kirchhammer, Mélanie Buchi, Julia Festag, Sven Michel, Rainer H Kohler, Elham Jones, Andre Maaske, Abhishek S Kashyap, Frank Jaschinski, Karen O Dixon, Mikaël J Pittet, Alfred Zippelius
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity. Journal for immunotherapy of cancer 11 (5) (2023)
Marcel Philipp Trefny, Nicole Kirchhammer, Priska Auf der Maur, Marina Natoli, Dominic Schmid, Markus Germann, Laura Fernandez Rodriguez, Petra Herzig, Jonas Lötscher, Maryam Akrami, Jane C Stinchcombe, Michal A Stanczak, Andreas Zingg, Melanie Buchi, Julien Roux, Romina Marone, Leyla Don, Didier Lardinois, Mark Wiese, Lukas T Jeker, Mohamed Bentires-Alj, Jérémie Rossy, Daniela S Thommen, Gillian M Griffiths, Heinz Läubli, Christoph Hess, Alfred Zippelius
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy. Nature communications 14 (1) (2023)
Marcel Philipp Trefny, Nicole Kirchhammer, Priska Auf der Maur, Marina Natoli, Dominic Schmid, Markus Germann, Laura Fernandez Rodriguez, Petra Herzig, Jonas Lötscher, Maryam Akrami, Jane C Stinchcombe, Michal A Stanczak, Andreas Zingg, Melanie Buchi, Julien Roux, Romina Marone, Leyla Don, Didier Lardinois, Mark Wiese, Lukas T Jeker, Mohamed Bentires-Alj, Jérémie Rossy, Daniela S Thommen, Gillian M Griffiths, Heinz Läubli, Christoph Hess, Alfred Zippelius
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy. Nature communications 14 (1) (2023)
Laura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, Marcel Philipp Trefny, Richard Klar, Nicole Kirchhammer, Mélanie Buchi, Julia Festag, Sven Michel, Rainer H Kohler, Elham Jones, Andre Maaske, Abhishek S Kashyap, Frank Jaschinski, Karen O Dixon, Mikaël J Pittet, Alfred Zippelius
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity. Journal for immunotherapy of cancer 11 (5) (2023)
Marcel Philipp Trefny, Nicole Kirchhammer, Priska Auf der Maur, Marina Natoli, Dominic Schmid, Markus Germann, Laura Fernandez Rodriguez, Petra Herzig, Jonas Lötscher, Maryam Akrami, Jane C Stinchcombe, Michal A Stanczak, Andreas Zingg, Melanie Buchi, Julien Roux, Romina Marone, Leyla Don, Didier Lardinois, Mark Wiese, Lukas T Jeker, Mohamed Bentires-Alj, Jérémie Rossy, Daniela S Thommen, Gillian M Griffiths, Heinz Läubli, Christoph Hess, Alfred Zippelius
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy. Nature communications 14 (1) (2023)
Omar S Sarkar, Howard Donninger, Numan Al Rayyan, Lewis C Chew, Bryce Stamp, Xiang Zhang, Aaron Whitt, Chi Li, Melissa Barousse Hall, Robert A Mitchell, Alfred Zippelius, John Eaton, Jason A Chesney, Kavitha Yaddanapudi
Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy. Science advances 9 (26) (2023)
Nicole Kirchhammer, Marcel Philipp Trefny, Priska Auf der Maur, Heinz Laubli, Alfred Zippelius
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment. Science translational medicine 14 (670) (2022)
Michal A Stanczak, Natalia Rodrigues Mantuano, Nicole Kirchhammer, David E Sanin, Francis Jacob, Ricardo Coelho, Arun V Everest-Dass, Jinyu Wang, Marcel Philipp Trefny, Gianni Monaco, Anne Bärenwaldt, Melissa A Gray, Adam Petrone, Abhishek S Kashyap, Katharina Glatz, Benjamin Kasenda, Karl Normington, James Broderick, Li Peng, Oliver M T Pearce, Erika L Pearce, Carolyn R Bertozzi, Alfred Zippelius, Heinz Laubli
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade. Science translational medicine 14 (669) (2022)
Karlijn Hummelink, Vincent van den Noort, Mirte Muller, Robert D Schouten, Ferry Lalezari, Dennis Peters, Willemijn S M E Theelen, Viktor Hendrik Koelzer, Kirsten D Mertz, Alfred Zippelius, Michel van den Heuvel, Annegien Broeks, John B A G Haanen, Ton N M Schumacher, Gerrit A Meijer, Egbert F Smit, Kim Monkhorst, Daniela S Thommen
PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (22) (2022)
Marina Natoli, Klas Hatje, Pratiksha Gulati, Fabian Junker, Petra Herzig, Zhiwen Jiang, Iakov I Davydov, Markus Germann, Marta Trüb, Daniel Marbach, Adrian Zwick, Patrick Weber, Stefan Seeber, Mark Wiese, Didier Lardinois, Viola Heinzelmann-Schwarz, Robert Rosenberg, Lothar Tietze, Kirsten D Mertz, Pablo Umaña, Christiane Neumann, Laura Codarri-Deak, Henry Kao, Alfred Zippelius
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors. Journal for immunotherapy of cancer 10 (11) (2022)
Nicole Kirchhammer, Marcel Philipp Trefny, Marina Natoli, Dominik Brücher, Sheena N Smith, Franziska Werner, Victoria Koch, David Schreiner, Ewelina Magdalena Bartoszek, Mélanie Buchi, Markus Schmid, Daniel Breu, K Patricia Hartmann, Polina Zaytseva, Daniela S Thommen, Heinz Laubli, Jan Philipp Böttcher, Michal A Stanczak, Abhishek S Kashyap, Andreas Plückthun, Alfred Zippelius
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity. Science translational medicine 14 (653) (2022)
Ana Luísa Correia, Joao C Guimaraes, Priska Auf der Maur, Duvini De Silva, Marcel Philipp Trefny, Ryoko Okamoto, Sandro Bruno, Alexander Schmidt, Kirsten D Mertz, Katrin Volkmann, Luigi Terracciano, Alfred Zippelius, Marcus Vetter, Christian Kurzeder, Walter Paul Weber, Mohamed Bentires-Alj
Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy. Nature 594 (7864) (2021)
Paula Voabil, Marjolein de Bruijn, Lisanne M Roelofsen, Sanne H Hendriks, Simone Brokamp, Marlous van den Braber, Annegien Broeks, Joyce Sanders, Petra Herzig, Alfred Zippelius, Christian U Blank, Koen J Hartemink, Kim Monkhorst, John B A G Haanen, Ton N M Schumacher, Daniela S Thommen
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer. Nature medicine 27 (7) (2021)
Natalia Rodrigues Mantuano, Marina Natoli, Alfred Zippelius, Heinz Laubli
Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy. Journal for immunotherapy of cancer 8 (2) (2021)
Marta Trüb, Franziska Uhlenbrock, Christina Claus, Petra Herzig, Martin Thelen, Vaios Karanikas, Marina Bacac, Maria Amann, Rosemarie Albrecht, Claudia Ferrara-Koller, Daniela Thommen, Sacha Rothschield, Spasenija Savic Prince, Kirsten D Mertz, Gieri Cathomas, Robert Rosenberg, Viola Heinzelmann-Schwarz, Mark Wiese, Didier Lardinois, Pablo Umana, Christian Klein, Heinz Laubli, Abhishek S Kashyap, Alfred Zippelius
Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer. Journal for immunotherapy of cancer 8 (2) (2021)
Yi-Ru Yu, Hana Imrichova, Haiping Wang, Tung Chao, Zhengtao Xiao, Min Gao, Marcela Rincon-Restrepo, Fabien Franco, Raphael Genolet, Wan-Chen Cheng, Camilla Jandus, Sergio A Quezada, Yi-Fan Jiang, Jason W Locasale, Alfred Zippelius, Pu-Ste Liu, Li Tang, Christoph Bock, Nicola Vannini, Ping-Chih Ho
Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion. Nature immunology 21 (12) (2020)